Gynazol (Butoconazole Nitrate)

Gynazol is indicated for the treatment of vulvovaginal candidiasis, a common yeast infection of the vaginal and vulvar tissues.

• Treatment of acute vulvovaginal candidiasis caused by Candida species.
• Management of recurrent vulvovaginal yeast infections when prescribed by a healthcare professional.
• Use as part of a therapeutic regimen for patients with confirmed fungal infection of the vagina.
• Adjunct to hygiene measures to reduce symptoms such as itching, burning, and discharge.
• Option for patients who require a locally acting antifungal with a different mechanism than azoles like fluconazole.

The safety profile of Gynazol reflects the typical adverse events associated with topical imidazole antifungals.

Common

• Mild vaginal irritation or burning at the application site.
• Itching or redness of the surrounding skin.
• Unusual vaginal discharge that is watery or slightly cloudy.
• Temporary increase in vaginal discomfort during the first 24–48 hours.

Serious

• Severe allergic reaction such as swelling of the lips, tongue, or throat.
• Persistent or worsening vaginal irritation that does not improve after several days.
• Development of a new rash or hives elsewhere on the body.

Before using Gynazol, patients should consider several precautionary measures to ensure safe and effective treatment.

• Confirm diagnosis of vulvovaginal candidiasis with a healthcare provider before starting therapy.
• Avoid use if you have a known hypersensitivity to butoconazole nitrate or any imidazole compounds.
• Do not apply the product on inflamed, ulcerated, or broken skin in the vaginal area.
• Discuss pregnancy, planned pregnancy, or breastfeeding with a clinician, as safety data are limited.
• Inform your doctor of any concurrent vaginal medications, including douches, spermicides, or hormonal creams.
• Keep the product out of reach of children and store it according to label instructions.

Gynazol may interact with other vaginal products or systemic medications that affect fungal growth or hormone balance.

Avoid

• Concurrent use of other topical antifungal agents (e.g., clotrimazole, miconazole) without medical advice.
• Simultaneous application of vaginal contraceptives or spermicidal gels that could alter drug absorption.
• Use with systemic azole antifungals (e.g., fluconazole) unless directed by a prescriber, due to overlapping mechanisms.

Use with caution

• Hormonal vaginal therapies (e.g., estrogen creams) that may change vaginal pH.
• Antibiotics that disrupt normal vaginal flora, potentially affecting treatment outcome.
• Herbal or over-the-counter products that claim antifungal activity; discuss with a clinician.